The natural course of migraine attacks. A prospective analysis of untreated attacks compared with attacks treated with a triptan

Cephalalgia. 2006 Jun;26(6):712-21. doi: 10.1111/j.1468-2982.2006.01097.x.

Abstract

This study was designed to document prospectively and explore scientifically the natural course of untreated migraine attacks in detail. A new, integrated, time-intensity method for self-assessment of the intensity of symptoms was tested on 18 adult International Headache Society migraineurs who volunteered to refrain from treatment during one attack. The area under the curves (AUC) during 72 h of untreated attacks was compared with attacks treated with a triptan. Migraine attacks are heterogeneous both inter- and intra-individually. In untreated attacks, the pain can stabilize and fluctuate around a plateau with a wavelength of hours. In general, the symptoms of each separate migraine attack follow a similar temporal course, with only moderate deviations. In some cases photo- and/or phonophobia (hyperexcitability) were not experienced at all, despite severe pain and nausea. Moreover, there was sometimes no nausea despite severe pain and hyperexcitability. Vomiting does not always correlate to the intensity of nausea and is not always followed by decreased headache intensity. Treatment with a triptan usually only temporarily distorts the basic pattern of attacks. Hyperexcitability can respond before pain to treatment. These genuine findings of the classic symptoms of migraine attacks support the notion of a mutual underlying pathophysiological mechanism.

Publication types

  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Comorbidity
  • Cross-Over Studies
  • Disease Progression
  • Female
  • Humans
  • Hyperacusis / epidemiology
  • Hyperacusis / prevention & control
  • Incidence
  • Male
  • Middle Aged
  • Migraine Disorders / diagnosis
  • Migraine Disorders / drug therapy*
  • Migraine Disorders / epidemiology*
  • Nausea / epidemiology
  • Nausea / prevention & control
  • Pain Measurement / drug effects
  • Pain Measurement / statistics & numerical data
  • Prognosis
  • Prospective Studies
  • Risk Assessment / methods*
  • Risk Factors
  • Serotonin Receptor Agonists
  • Severity of Illness Index
  • Sumatriptan / administration & dosage*
  • Sweden / epidemiology
  • Treatment Outcome
  • Tryptamines / therapeutic use*
  • Vasoconstrictor Agents / administration & dosage
  • Vomiting / epidemiology
  • Vomiting / prevention & control

Substances

  • Serotonin Receptor Agonists
  • Tryptamines
  • Vasoconstrictor Agents
  • Sumatriptan